SCHEMBL3687402

SCHEMBL3687402

O=C(O)c1nc2c(C(F)(F)F)cc(-c3cccc(F)c3)cn2c1I

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.41
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMO O15229 2/20 0.37
CYP11B2 P19099 1/20 0.37
LDHA P00338 2/20 0.36
NT5E P21589 2/20 0.36
ACHE P22303 1/20 0.35
PTGS2 P35354 2/20 0.35
PTGS1 P23219 1/20 0.35
DHODH Q02127 2/20 0.35
POLB P06746 1/20 0.35
DCLRE1B Q9H816 1/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3689791 0.87 PIN1 (0.41) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3691090 0.87 PIN1 (0.41) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3688388 0.87 PIN1 (0.41) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3687966 0.83 PIN1 (0.38) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3689315 0.82 PIN1 (0.38) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3689316 0.82 PIN1 (0.38) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3688448 0.81 GRIN2B (0.37) PIN1KDM4EALDH1A1PTGS2DHODH
SCHEMBL3686132 0.81 PIN1 (0.36) PIN1KDM4EALDH1A1KMOCYP11B2
SCHEMBL3688395 0.80 KDM4E (0.39) PIN1KDM4EALDH1A1CYP11B2LDHA
Pyridine SCHEMBL3647233 0.80 PIN1 (0.36) PIN1KDM4EALDH1A1KMOCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
EP-2187883-A2 NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2010-05-26 EP disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
WO-2009023179-A2 NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections OAT, HAVCR2, CPS1 PIN1 1508/4885KDM4E 2131/4885ALDH1A1 1337/4885
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections OAT, HAVCR2, CPS1 PIN1 1508/4885KDM4E 2131/4885ALDH1A1 1337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.